Helicobacter pylori infection of gastric cancercells elevates the level of expression and activation of protein kinase D2
Aim: To test the hypothesis, whether H. pylori infection may affect the level of PKD2 expression and/or activation in gastric cancer cells. Methods: Studies were performed on AGS human gastric adenocarcinoma cell line, gastric tissues samples from 36 cases of different histological variants of gastr...
Збережено в:
Дата: | 2009 |
---|---|
Автори: | , , , , |
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2009
|
Назва видання: | Experimental Oncology |
Теми: | |
Онлайн доступ: | http://dspace.nbuv.gov.ua/handle/123456789/138136 |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
Цитувати: | Helicobacter pylori infection of gastric cancercells elevates the level of expression and activation of protein kinase D2 / M.Yu. Shabelnik, O.V. Kostyuk, S.V. Merentsev, T.O. Tarasova, S.P. Sidorenko // Experimental Oncology. — 2009. — Т. 31, № 3. — С. 134-139. — Бібліогр.: 38 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraineid |
irk-123456789-138136 |
---|---|
record_format |
dspace |
spelling |
irk-123456789-1381362018-06-19T03:02:49Z Helicobacter pylori infection of gastric cancercells elevates the level of expression and activation of protein kinase D2 Shabelnik, M.Yu Kostyuk, O.V. Merentsev, S.V. Tarasova, T.O. Sidorenko, S.P. Original contributions Aim: To test the hypothesis, whether H. pylori infection may affect the level of PKD2 expression and/or activation in gastric cancer cells. Methods: Studies were performed on AGS human gastric adenocarcinoma cell line, gastric tissues samples from 36 cases of different histological variants of gastric cancer. Immunohistochemical, cell and molecular biology, bacteriological and biochemical approaches have been used in this study. Results: H. pylori 16S rRNA gene was detected in 97% cases of gastric tumors, and in 83% of cases cаgA gene was detected. In all tested adenocarcinoma samples cagA+ H. pylori was revealed. These cases were characterized by high level of PKD1/2 expression and autophosphorylation. In adenogenic cancer samples the presence of cagA– H. pylori was identified. Carcinoid and nondifferentiated gastric cancers contain H. pylori, with very low numbers of cagA+ copies. All cases of gastric tumors with cagA– H. pylori had very low levels of PKD1/2 autophosphorylation. AGS cell line infection with cagA– and cagA+ H. рylori resulted in elevation of PKD2 expression levels in 3.29 and 3.66 times respectively (p < 0.001). In cells infected by cag+ H. рylori the level of PKD2 transphosphorylation was 1.39 higher than in cells infected by cagA– H. pylori. For PKD2 autophosphorylation this difference was even higher — 3.27 times (p < 0.001). Conclusion: H. pylori infection enhanced the level of protein kinase D2 expression, trans- and autophosphorylation. The level of PKD2 autophosphorylation/activation was higher in AGS cell line inoculated of with cag+ H. pylori than in AGS cells with cagA– H. pylori. These suggest that H. pylori induces activation of PKD1/2 and could exploit PKD2 mediated signaling pathways that may contribute to the pathogenesis of gastric cancer. 2009 Article Helicobacter pylori infection of gastric cancercells elevates the level of expression and activation of protein kinase D2 / M.Yu. Shabelnik, O.V. Kostyuk, S.V. Merentsev, T.O. Tarasova, S.P. Sidorenko // Experimental Oncology. — 2009. — Т. 31, № 3. — С. 134-139. — Бібліогр.: 38 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/138136 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
collection |
DSpace DC |
language |
English |
topic |
Original contributions Original contributions |
spellingShingle |
Original contributions Original contributions Shabelnik, M.Yu Kostyuk, O.V. Merentsev, S.V. Tarasova, T.O. Sidorenko, S.P. Helicobacter pylori infection of gastric cancercells elevates the level of expression and activation of protein kinase D2 Experimental Oncology |
description |
Aim: To test the hypothesis, whether H. pylori infection may affect the level of PKD2 expression and/or activation in gastric cancer cells. Methods: Studies were performed on AGS human gastric adenocarcinoma cell line, gastric tissues samples from 36 cases of different histological variants of gastric cancer. Immunohistochemical, cell and molecular biology, bacteriological and biochemical approaches have been used in this study. Results: H. pylori 16S rRNA gene was detected in 97% cases of gastric tumors, and in 83% of cases cаgA gene was detected. In all tested adenocarcinoma samples cagA+ H. pylori was revealed. These cases were characterized by high level of PKD1/2 expression and autophosphorylation. In adenogenic cancer samples the presence of cagA– H. pylori was identified. Carcinoid and nondifferentiated gastric cancers contain H. pylori, with very low numbers of cagA+ copies. All cases of gastric tumors with cagA– H. pylori had very low levels of PKD1/2 autophosphorylation. AGS cell line infection with cagA– and cagA+ H. рylori resulted in elevation of PKD2 expression levels in 3.29 and 3.66 times respectively (p < 0.001). In cells infected by cag+ H. рylori the level of PKD2 transphosphorylation was 1.39 higher than in cells infected by cagA– H. pylori. For PKD2 autophosphorylation this difference was even higher — 3.27 times (p < 0.001). Conclusion: H. pylori infection enhanced the level of protein kinase D2 expression, trans- and autophosphorylation. The level of PKD2 autophosphorylation/activation was higher in AGS cell line inoculated of with cag+ H. pylori than in AGS cells with cagA– H. pylori. These suggest that H. pylori induces activation of PKD1/2 and could exploit PKD2 mediated signaling pathways that may contribute to the pathogenesis of gastric cancer. |
format |
Article |
author |
Shabelnik, M.Yu Kostyuk, O.V. Merentsev, S.V. Tarasova, T.O. Sidorenko, S.P. |
author_facet |
Shabelnik, M.Yu Kostyuk, O.V. Merentsev, S.V. Tarasova, T.O. Sidorenko, S.P. |
author_sort |
Shabelnik, M.Yu |
title |
Helicobacter pylori infection of gastric cancercells elevates the level of expression and activation of protein kinase D2 |
title_short |
Helicobacter pylori infection of gastric cancercells elevates the level of expression and activation of protein kinase D2 |
title_full |
Helicobacter pylori infection of gastric cancercells elevates the level of expression and activation of protein kinase D2 |
title_fullStr |
Helicobacter pylori infection of gastric cancercells elevates the level of expression and activation of protein kinase D2 |
title_full_unstemmed |
Helicobacter pylori infection of gastric cancercells elevates the level of expression and activation of protein kinase D2 |
title_sort |
helicobacter pylori infection of gastric cancercells elevates the level of expression and activation of protein kinase d2 |
publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
publishDate |
2009 |
topic_facet |
Original contributions |
url |
http://dspace.nbuv.gov.ua/handle/123456789/138136 |
citation_txt |
Helicobacter pylori infection of gastric cancercells elevates the level of expression and activation of protein kinase D2 / M.Yu. Shabelnik, O.V. Kostyuk, S.V. Merentsev, T.O. Tarasova, S.P. Sidorenko // Experimental Oncology. — 2009. — Т. 31, № 3. — С. 134-139. — Бібліогр.: 38 назв. — англ. |
series |
Experimental Oncology |
work_keys_str_mv |
AT shabelnikmyu helicobacterpyloriinfectionofgastriccancercellselevatesthelevelofexpressionandactivationofproteinkinased2 AT kostyukov helicobacterpyloriinfectionofgastriccancercellselevatesthelevelofexpressionandactivationofproteinkinased2 AT merentsevsv helicobacterpyloriinfectionofgastriccancercellselevatesthelevelofexpressionandactivationofproteinkinased2 AT tarasovato helicobacterpyloriinfectionofgastriccancercellselevatesthelevelofexpressionandactivationofproteinkinased2 AT sidorenkosp helicobacterpyloriinfectionofgastriccancercellselevatesthelevelofexpressionandactivationofproteinkinased2 |
first_indexed |
2025-07-10T02:47:31Z |
last_indexed |
2025-07-10T02:47:31Z |
_version_ |
1837226424927256576 |
fulltext |
134 Experimental Oncology 31, 134–139, 2009 (September)
Malignant transformation of cells is a complex
process, which involves the accumulation of multiple
independent mutations that lead to deregulation of cell
signaling pathways that control cell growth, prolifera-
tion, differentiation and apoptosis [1]. Recent progress
in biomedical sciences has identified a number of mo-
lecular pathways and cellular mechanisms that underline
the multistage process of tumorogenesis and metastasis
formation. It was shown that serine/threonine protein
kinases could be involved in the integration of different
signaling pathways in normal and malignant cells [2].
Protein kinase D (PKD) family within the group
of calcium/calmodulin-dependent protein kinases
(CAMK) consists of three members: PKD1/PKCμ,
PKD2 and PKD3/PKCν. These kinases share high
structural homology but differ in cell specific expres-
sion, intracellular distribution and, most probably,
in substrate specificity and cellular function [2]. Full
activation of PKD involves phosphorylation of Ser resi-
dues within different structural modules. Transphos-
phorylation sites in so-called “activation loop” of PKDs
are substrate for PKCs phosphorylation. Autophos-
phorylation sites have been mapped in C-terminus
of PKD1 and PKD2 and serves as indicator of kinase
activation [3].
It is known that PKDs are activated by a range
of cell surface receptors and pharmacological agents
that could induce PKDs intracellular redistribution.
PKD may be localized in the cytosol and in several
intracellular compartments including nucleus, Golgi
apparatus, plasma membrane and mitochondria. De-
pending on site of localization PKDs can be implicated
in the regulation of a variety of cellular processes,
including Golgi apparatus function and organization,
receptors signalling, tumor cell spreading and moti-
lity that promote tumor invasion [2, 4].The presence
of the nuclear translocation signal peptide may sug-
gest that upon stimulation PKDs are translocated
into the nucleus and phosphorylate nuclear targets,
such as histone deacetylases and histone chaperone
SET [5]. Moreover, indirectly PKDs could be involved
in activation of transcription factor NF-κB [6]. In this
way, PKD kinases are implicated in epigenetic regula-
tion of gene expression [5].
PKD2 is the main serine/threonine protein kinase
of PKD family, which is expressed in AGS cell line. In this
cell line PKD2 is activated by gastrin and is a down-
stream target of PKCs [7, 8]. However, little is known
about the expression and activity of PKD2 as well
as PKD1 in primary gastric cancer cells.
H. pylori is a widespread chronic infection agent,
that is considered to be aetiologycal factor for gastric
and duodenal ulcer, MALT-lymphoma and gastric ade-
nocarcinoma [9]. At the same time, the role H. pylori
HELICOBACTER PYLORI INFECTION OF GASTRIC CANCER
CELLS ELEVATES THE LEVEL OF EXPRESSION AND ACTIVATION
OF PROTEIN KINASE D2
M.Yu. Shabelnik1, O.V. Kostyuk2, S.V. Merentsev3, T.O. Tarasova4, S.P. Sidorenko1, *
1R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kiev 03022, Ukraine
2A.A. Bogomolets National Medical University, Kiev 04053, Ukraine
3Kiev City Oncоlogical Hospital, Kiev 03115, Ukraine
4State National Institute of Cancer, Kiev 03022, Ukraine
Aim: To test the hypothesis, whether H. pylori infection may affect the level of PKD2 expression and/or activation in gastric cancer cells.
Methods: Studies were performed on AGS human gastric adenocarcinoma cell line, gastric tissues samples from 36 cases of different
histological variants of gastric cancer. Immunohistochemical, cell and molecular biology, bacteriological and biochemical approaches
have been used in this study. Results: H. pylori 16S rRNA gene was detected in 97% cases of gastric tumors, and in 83% of cases cаgA
gene was detected. In all tested adenocarcinoma samples cagA+ H. pylori was revealed. These cases were characterized by high level
of PKD1/2 expression and autophosphorylation. In adenogenic cancer samples the presence of cagA– H. pylori was identified. Car
cinoid and nondifferentiated gastric cancers contain H. pylori, with very low numbers of cagA+ copies. All cases of gastric tumors with
cagA– H. pylori had very low levels of PKD1/2 autophosphorylation. AGS cell line infection with cagA– and cagA+ H. рylori resulted
in elevation of PKD2 expression levels in 3.29 and 3.66 times respectively (p < 0.001). In cells infected by cag+ H. рylori the level
of PKD2 transphosphorylation was 1.39 higher than in cells infected by cagA– H. pylori. For PKD2 autophosphorylation this diffe
rence was even higher — 3.27 times (p < 0.001). Conclusion: H. pylori infection enhanced the level of protein kinase D2 expression,
trans and autophosphorylation. The level of PKD2 autophosphorylation/activation was higher in AGS cell line inoculated of with
cag+ H. pylori than in AGS cells with cagA– H. pylori. These suggest that H. pylori induces activation of PKD1/2 and could exploit
PKD2 mediated signaling pathways that may contribute to the pathogenesis of gastric cancer.
Key Words: gastric cancer, protein kinase D, AGS cell line, Helicobacter рylori, CagA.
Received: July 20, 2009.
*Correspondence: Fax: 38 (044) 258-16-56
E-mail: svitasyd@yahoo.com
Abbreviation used: AGS — adenocarcinoma gastric cell line;
АР-1 — activator protein; CAMK — calcium/calmodulin-dependent
protein kinase; Csk — C-terminal Src kinase; MIF — macrophage
migration inhibitory factor; NF-kB — nuclear factor -kB; PKC —
protein kinase C; PKD — protein kinase D.
Exp Oncol 2009
31, 3, 134–139
ORIGINAL CONTRIbuTIONS
Experimental Oncology 31, 134–139, 2009 (September) 135
infection in pathogenesis of gastric cancer is not com-
pletely clarified.
Virulent H. pylori strains harbor a cagA pathogeni-
city island for delivery of the bacterial CagA protein into
gastric epithelial cells [10, 11]. CagA is transported into
the host target cells and subsequently phosphorylated.
Clearly this is a mechanism by which H. pylori could take
control of one or more host cell signal transduction path-
ways [10]. Presumably the final result of this interaction
favors survival of H. pylori, irrespective of eventual da-
mage to the host cell. After translocation, CagA is phos-
phorylated by Src family kinases at the tyrosine residue
in the EPIYA sequence repeats [12]. Phosphorylation
of CagA is accompanied by high motility and elonga-
tion of cells, the so-called hummingbird phenotype
[13]. CagA has been shown to interact with a number
of host signaling molecules, such as the adaptor
molecule Grb-2, tyrosine phosphatase SHP-2, Src,
and C-terminal Src kinase (Csk) to induce inactivation
of Src kinase and dephosphorylation of cortactin [14].
It was also shown, that infection by H. pylori induced
signal transduction pathways that involve РКС kinases
[15, 16]. PKCs phosphorylate and activate kinases
of PKD family [3]. Taking into account that previously
we have found heterogeneity in PKD1/2 autophos-
phorylation in gastric adenocarcinomas [17], in cur-
rent study we tested the hypothesis whether infection
by the H. pylori may affect the level of PKD2 expression
and/or activation in gastric cancer cells.
MATERIALS AND METHODS
Studies were performed on AGS cell line, gastric
tumor samples and surrounding normal tissues of sto-
mach (29 cases of adenocarcinomas with different level
of differentiation, 3 — cases of adenogenic cancer, 2 —
cases of nondifferentiated cancer, 1 — case of carci-
noid tumor, 1 — case of adenoma). Gastric tumors were
classified and graded according to WHO classification
on the basis of combination of morphologic and clini-
cal characteristics [18]. The usage of tissue samples
was approved by the Institutional Review Board and Re-
search Ethics Committee of R.E. Kavetsky Institute
of Experimental Pathology, Oncology and Radiobiology,
National Academy of Sciences of Ukraine.
Polyclonal rabbit antibodies, that recognize both
PKD1 and PKD2 kinases (anti-PKD1/2) and auto-
phosphorylated sites in both PKD1 and PKD2 (anti-
pPKD1/2) (kind gift of Prof. VanLint, Belgium), PKD2
(Calbiochem, USA), Ser876 in PKD2 (autophospho-
rylated pPKD2) (Upstate, USA), Ser 744/748 in PKD2
(transphosphorylated ppPKD2) (Cell Signaling, USA)
and goat anti-actin antibodies (Santa Cruz, CA, USA)
were used as primary antibodies. EnVision detec-
tion system (DAKO, Denmark), goat anti-rabbit IgG-
HRP and donkey anti-goat IgG-HRP (Santa Cruz, CA,
USA) were applied as a secondary antibodies.
Immunohistochemistry. Tissue samples of all
studied cases were fixed in 4% paraformaldehyde
and embedded in paraffin. Immunohistochemistry
stu dies of PKD1 and PKD2 were performed on de-
paraffined tissues sections. We used specific anti-
PKD1/2 antibodies that recognized both isoforms.
The levels of autophosphorylated PKD1 and PKD2 were
used as a criterion of activated PKD1/2 and were ac-
cessed with anti-pPKD1/2 serum, which recognize con-
served autophosphorylation site in PKD1 and PKD2.
To reduce non-specific background, prior to spe-
cific antibodies, sections were treated with normal
goat serum and 1% BSA solution. EnVision detection
system was used in 45 min second-step incubation.
After washing in phosphate-buffered saline peroxidase
activity was assayed using DAB. Section were counter-
stained with hematoxylin for 1 min, embedded in balm,
and studied under the microscope.
Isolation and cultivation of H. pylori. For isola-
tion we used samples of pyloric antrum of the sto-
mach from 4 patients with gastric ulcer (Department
of Therapy № 2 of A.A. Bogomolets National Medical
University, Kiev, Ukraine). For tissue sample trans-
portation we used Stuart’s transport medium (Merck,
USA). Prior inoculation, material was homogenized
in 0.5 ml of sterile PBS or brain heart infusion broth du-
ring 1 min. Selective medium Agar pylori (Bio Merieux,
France) and nonselective — Columbia agar with 10%
of the sheep blood (Bio Merieux, France) were ino-
culated with gomogenized tissues. Tissues dishes
were incubated in GENbox Jar (Bio Merieux, France),
in microaerofilic condition that was created by spe-
cial gas generation packages (Bio Merieux, France)
at 37 °C during 7 days.
Typing of bacterial cultures was performed using
cultural, morphological, tinctorial and enzymatic cri-
teria. Selected cultures of Н. pylori were subcultivated
on Columbia agar with 10% of horse blood in microaero-
filic condition at 37 °C during 48–72 h. For inoculation
of AGS cell line we used only “young” cultures of H. py-
lori, that had less than 25% of coccal forms and in size
of the 108 CFU on Mac-Farland̓s scale.
Inoculation AGS cell line with Н. pylori. AGS cell
line was cultivated with cagA– and cagA+ Н. pylori cultures
during 4.5 h and proteins were extracted using Triton-
X100 lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl,
1% Triton-X100, 5 mM EDTA) with cocktail of inhibitors
of proteases and phosphatases (Sigma, USA).
Western blot analysis. Western blot analysis
was performed using rabbit anti-PKD2, anti-ppPKD1/2
(Ser 744/748), and anti-pPKD2 (Ser876) rabbit sera.
The cells from cell cultures were lysed using Tri-
ton-X100 lysis buffer with cocktail of inhibitors of pro-
teases and phosphatases (Sigma, USA). Lysates were
subjected to SDS-PAGE on 7.5% gels. Proteins were
transferred to Immobilon-NC membranes (Millipore,
USA) and blocked during overnight incubation with 5%
nonfat dried milk in TBS-T. Membranes were incubated
with primary antisera at 4 °C for 12 h and with seconda-
ry antibodies for 2 h. For semiquantitative evaluation
of Western blot analysis Total lab software version 2.01
(Phoretix, Nonlinear Dynamics Ltd) was applied.
DNA isolation and polymerase chain reaction
for H. pylori identification. DNA isolation was per-
136 Experimental Oncology 31, 134–139, 2009 (September)
formed using TRI reagent (Sigma, USA) according
to manufacturers protocol. DNA pellet was dissolved
in TE buffer. For polymerase chain reaction (PCR)
we used 0.5 μg of DNA for each probe. The universal
primers for H. pylori detection in gastric tissue included
two oligonucleotides designed to amplify 16S rRNA
(Maxim Biotech. Inc., USA), (GenBank Acession No.:
U00679) the 5’Oligo: СTGGAGAGACTAAGCCCTCC
and the 3ʼOligo: ATTACTGACGCTGATTGTGC, which
generated a 110-bp product. PCR amplification with
specific primers was performed according to standard
protocol: thirty five cycles, with each cycle consis-
ting of denaturation step at 94 °C, annealing step
at 58 °C and extension step at 72 °C. The specific pri-
mers for PCR amplification of cagA H. pylori (Helicopol
Ca, Russia), which generated a 404-bp product, were
used for identification of cagA+ strains of H. pylori.
Thirty five cycles were performed, with each cycle
consisting of denaturizing step at 94 °C, annealing
step at 52 °C, and extension step at 72 °C. Each experi-
ment included negative and positive controls provided
by manufacturers.
Statistical analysis. Statistical significance of dif-
ferences was evaluated by Student’s t-test.
RESuLTS AND DISCuSSION
Starting from our previous results that showed hete-
rogeneity of primary adenocarcinoma cancer samples
by expression levels of PKD1 and PKD2 and auto-
phosphorylation/activation, we found that diffe rent
histological variants of gastric cancer also vary
in the level of PKD1/2 autophosphorylation. The high
level of PKD1/2 autophosphorylation was detected
in adenocarcinomas with moderate level of differ-
entiation (Fig. 1, a), whereas in adenogenic cancer
the level of PKD1/2 autophosphorylation was very
low or undetectable (Fig. 1, b). At the same time,
benign tumor (adenoma) demonstrated high level
of PKD1/2 autophosphorylation (Fig. 1, с). Heteroge-
neity of gastric cancer primary samples by PKD1/2 au-
tophosphorylation could depend not only on the level
of cell differentiation [17], but also reflect tumor cell
activation with infectious agents. Since H. pylori in-
fection was shown to trigger PKC-mediated signaling
pathway [15, 16], and activity (autophosphorylation)
of PKD kinases is regulated by PKCs [2, 19], we ana-
lyzed the pre sence of H. pylori in the primary gastric
tumor samples and addressed the question whether
H. pylori could induce PKD phosphorylation.
The 16S rRNA gene of H. pylori is a highly specific
target for amplification and has been used previously
to help reclassify these bacteria [20]. Weiss et al. [21]
have demonstrated the specificity of unique H. pylori
16S rRNA gene primers to identify the bacteria in pa-
raffin-embedded gastric biopsy specimens. In primary
tissue samples we found that 97% (35 from 36) cases
of examined gastric tumors contain H. pylori 16S rRNA
(Fig. 2, a) that is comparable to the previously pub-
lished data [22].
a
b
c
Fig. 1. The level of PKD1/2 autophosphorylation in gastric
tumors, immunohistochemical staining. a, adenocarcinoma;
b, adenogenic cancer; c, adenoma (X400)
1 2 3 4 5 6 7 8 9
16s RNA
CagA
DNA
a
b
c
Fig. 2. PCR analysis of DNA isolated from gastric tissue samples.
The presense of 16S rRNA (a) of H. pylori identify the bacteria
from frozen (1–4, 7) and in paraffin-embedded gastric biopsy
specimens (5–6, 8). b, cagA+ from H. pylori. c, Control of assayed
material (DNA). 1–5 — adenocarcinomas, 6 — adenogenic can-
cer, 7 — carcinoid cancer, 8 — nondifferentiated gastric cancer,
9 — positive control
Some strains of H. pylori have been shown to be more
pathogenic than others. Strains that possess CagA
are associated with increased severity of gastritis
and with additional risk for developing atrophic gastritis
and gastric cancer [23]. Moreover, it has been demon-
Experimental Oncology 31, 134–139, 2009 (September) 137
strated that after H. pylori infection, CagA is translocated
into the epithelial cells, and it undergoes tyrosine phos-
phorylation in the host cells. The phosphorylated form
of CagA might function as a phosphatase that regulates
host cell growth [24]. As we can find out, cаgA gene
was detected in 83% (30 from 36) cases of primary
tumor tissue samples (Fig. 2, b). It should be noted that
H. pylori cagA+ was revealed in all tested 29 adenocarci-
noma samples as well as gastric adenoma tissue sample
(see Fig. 2, a, b, tracks 1–5; other data not shown).
In two samples of adenogenic cancer cagA– gene H. py-
lori was identified, however one case of adenogenic
cancer can be considered as H. pylori negative, since
H. pylori 16S rRNA gene was not detected here (see
Fig. 2, a, b, track 6 and data not shown). In carcinoid
and nondifferentiated gastric cancer we found the pre-
sence of H. pylori, with very low numbers of cagA copies
(see Fig.2 a, b, tracks 7 and 8).
Since in our studies the presence of cagA+ H. pylori
in tumor tissues was correlated with the moderate
to high level of PKD1/2 autophosphorylation, we ad-
dressed the question whether H. pylori infection
may affect the level of PKD2 expression and/or trans-
and autophosphorylation. To test this hypothesis
we used the model gastric cancer cell line AGS which
was infected with H. pylori. Cultivation of AGS cell
line with cagA– or cagA+ H. pylori cultures during
4.5 h caused the elevation of PKD2 expression level
in comparison with the control cultures, moreover,
it resulted in PKD2 transphosphorylation (ppPKD2)
and autophosphorylation (pPKD2) (Fig. 3).
Control cell culture did not demonstrate PKD2 trans-
phosphorylation that is PKC-dependent. PKD2 in these
cultures was not activated and, accordingly, was not auto-
phosphorylated (see Fig. 3, a). At the same time, ino-
culation of AGS cell line with H. pylori led to substantial
PKD2 trans- and autophosphorylation reflecting the acti-
vation of this kinase. Furthermore, the level of PKD2 auto-
phosphorylation in AGS cell line inoculated with cagA+
H. pylori was much higher than that in cells inocula ted
with cagA– H. pylori (see Fig. 3, a). To evaluate H. рylori
induced changes in PKD2 expression and phosphoryla-
tion we have performed densitometric analysis of Western
blots with normalization to the level of actin expression
(see Fig. 3, b). As it is shown on the left panel of Fig. 3, b,
infection with cagA– and cagA+ of H. рylori led to elevation
of PKD2 expression by 3.29 and 3.66 times respectively
(p < 0.001). H. рylori infection dramatically increased both
trans- and autophosphorylation of PKD2. It worth to note
that in cultures with cagA+ H. рylori the level of transpho-
sphorylation (PKC-dependent) was by 1.39 times higher
than in cultures infected with cagA– H. рylori (p < 0.001).
For PKD2 autophosphorylation this difference was even
higher — 3.27 times (p < 0.001) (see Fig. 3, middle
and right panel).
The development of cancer is often associated
with chronic inflammation [25]. Inflammation is linked
to all stages of tumor development — initiation, progres-
sion and metastasis. Although the connection between
chronic inflammation and cancerogenesis has been well
established, the underlying mechanisms remain unclear
[25]. Recent studies have begun to unravel signaling
pathways linking inflammation and cancer [26].
105 kDa
42 kDa
PKD2
ppPKD2
pPKD2
Actin
0
10
20
30
40
50
60
70
80
90
100
Control CagA– CagA+
Control CagA– CagA+
Control CagA– CagA+
Control CagA– CagA+
PKD2
PK
D2
e
xp
re
ss
io
n
(r
el
at
ive
u
ni
ts
)
ppPKD2
0
10
20
30
40
50
60
70
80
90
100
PK
D2
tr
an
sp
ho
sp
ho
ry
la
tio
n
(r
el
at
ive
u
ni
ts
)
0
10
20
30
40
50
60
70
80
90
100 pPKD2
PK
D2
a
ut
op
ho
sp
ho
ry
la
tio
n(
re
la
tiv
e
un
its
)
a
b
Fig. 3. Protein expression, trans- and autophosphorylation
of PKD2 in AGS cell line after H. pylori infection. a, Western blot
analysis of PKD2 expression, transphosphorylation (ppPKD1/2),
and autophosphorylation (pPKD2). The level of actin expression
served as loading control. Control — noninfected AGS cell line,
cagA– — AGS cell line infected with cagA– culture of H. pylori.
cagA+ — AGS cell line infected with cagA+ culture of H. pylori.
b, Densitometry of Western blot analysis with normalization
to actin (p < 0.001)
H. pylori that infects over half of the world’s popu-
lation, usually persists in the gastric mucosa [27]
138 Experimental Oncology 31, 134–139, 2009 (September)
and confers risk of serious diseases, including peptic
ulceration and gastric neoplasia [28]. Н. pylori is the first
bacterium to be classified as a definite carcinogen
because of its epidemiologic relationship to gastric
adenocarcinoma and gastric mucosa-associated lym-
phoid tissue MALT lymphoma. Understanding how this
bacteria interacts with its host and affects biological
functions of epithelial cells via interaction with different
intracellular signaling pathways is essential for desig-
ning the strategy for optimized therapy [29].
Recently the mechanisms H. pylori interaction with
host cells have been clarified. H. pylori possesses over
30 genes related to the expression of outer membrane
proteins. Several of these proteins have been classi-
fied as adhesins, suggesting multiple and perhaps
redundant or variable modes of attachment to cell
surface. The best studied H. pylori adhesins are outer
membrane proteins that bind carbohydrate moie-
ties in host cell glycoproteins [29]. Bacterium also
use CD74 for adhesion to epithelial cells [30].
There are known several distal outcomes of H. pylori
interaction with gastric epithelial cell for example, activa-
tion of transcription factors NF-κB and АР-1, induction
of secretion of MIF, IL-8, IL-1β [30, 31], but the mecha-
nisms of signal transduction and intracellular pathways
utilized by this bacterium was not explored.
In our studies we tested the hypothesis whether
cagA+ and cagA– H. pylori can affect the PKD2 expres-
sion and activation.
Our study revealed the presence of H. pylori
in all exa mined 29 adenocarcinoma samples that
are characterized by high and moderate level
of PKD1/2 autophosphorylation. Moreover, all these
cases also were cagA+. Adenogenic and nondif-
ferentiated gastric cancer, and also carcinoid ones
had very low level of PKD1/2 aurophosphoryla-
tion and are cagA– or carry low numbers of cagA.
At the same time, benign tumor (adenoma) de-
monstrated high level of PKD1/2 autophosphorylation
and the presence of cagA+ H. pylori. Heterogeneity
of primary gastric cancer samples in PKD1/2 auto-
phosphorylation could depend on the level of cell
differentiation, but also reflect tumor cell activation
with infectious agents. Althoug the percent of H. pylori
positive gastric samples vary depending on age, geo-
graphical localization and ethnicity, H. pylori was de-
tected in vast majority of adenocarcinoma samples
[27, 32]. According to our data, H. pylori was detected
in all tested adenocarcinoma samples, moreover,
all studied adenocarcinoma cases were cagA+.
Correlation between the presence of cagA posi-
tive H. pylori and PKD1/2 phosphorylation may point
on causal link between infection and PKDs activation.
To test this assumption we employed experimental
model system. Indeed, H. pylori infection of AGS cell
line induced autophosphorylation/activation of PKD2
(see Fig. 3). This activation was PKC-dependent, since
PKD2 was phosphorylated at site Ser 744/748, which
is the target of PKC (see Fig. 3). Moreover, we found
that infection with either cagA– and cagA+ H. pylori also
elevated the level of PKD2 expression in AGS cell line.
Markedly, the cagA+ H. pylori was more potent than
cagA– H. pylori in elevation of PKD2 level (see Fig. 3, a).
It is obvious that increase of PKD2 activity was not de-
pendent on the level of PKD2 expression since in con-
trol cultures PKD phosphorylation was not detected.
There are several lines of evidence of the functional
link between H. pylori infection and PKDs activation.
First, H. pylori infection was shown to trigger PKC-
mediated signaling pathway [15, 16], and PKCs regu-
late activity (autophosphorylation) of PKD kinases [2,
19]. Second, both H. pylori and PKDs are involved in
NF-κB activation [27, 30]. Third, CagA targets an im-
portant cellular E-cadherin/β-catenin pathway, which
regulates epithelial junction formation, epithelial cell
adhesion, and control cell growth [33]. PKDs activity
is also involved in regulation of E-cadherin/β-catenin
pathway especially in tumor cells [34]. Fourth, both
PKDs and H. pylori are linked to regulation of HDAC
(histon deacetylases), which are involved in epigenetic
regulation of gene expression [28, 35]. Fifth, both regu-
late matrix metalloproteinase expression [36–38].
All these suggest that in order to affect host cell bio-
logical programs, H. pylori may use PKDs-mediated
signalling pathways.
In conclusion, using the model system of gastric
cancer cell line AGS we have shown that H. pylori
infection enhanced the levels of expression, trans-
and autophosphorylation of protein kinase PKD2, that
may lead to activation of signal transduction path-
ways, promoting cell proliferation and tumor invasion.
We also found that the level of PKD2 autophosphoryla-
tion/activation was higher in AGS cell line inoculated
of with cagA+ H. pylori than that in AGS cells with cagA–
H. pylori. H. pylori induced activation of PKD1/2 could
contribute to the pathogenesis of gastric cancer.
ACKNOWLEDGEMENTS
This work was supported in part by Ukrainian gov-
ernmental grants 010U000784, 0105U005557 and
0107U002244.
REFERENCES
Bild AH, Yao G, Chang JT, 1. et al. Oncogenic pathway
signatures in human cancers as a guide to targeted therapies.
Nature 2006; 439: 353–7.
Van Lint J, Rykх A, Maeda Y, 2. et al. Protein kinase D:
an intracellular traffic regulator on the move. Trends Cell
Biology 2002; 12: 193–200.
Rozengurt E, Rey O, Waldron RT. 3. Protein kinase D sig-
naling. J Biol Chem 2005; 280: 13205–8.
Hausser A, Link G, Bamberg L, 4. et al. Structural require-
ments for localization and activation of protein kinase Cμ (PKCμ)
at the Golgi compartment. J Cell Biol 2002; 156: 65–74.
Dequiedt F, Van Lint J, Lecomte E, 5. et al. Phosphoryla-
tion of histone deacetylase 7 by protein kinase D mediates
T cell receptor-induced Nur77 expression and apoptosis.
Exp Med 2005; 201: 793–804.
Mihailovic T, Marx M, Auer A, 6. et al. Protein kinase D2 me-
diates activation of nuclear factor kappaB by Bcr-Abl in Bcr-Abl+
human myeloid leukemia cells. Cancer Res 2004; 64: 8939–44.
Sturany S, Van Lint J, Muller F, 7. et al. Molecular cloning
and characterization of the human protein kinase D2. A novel
Experimental Oncology 31, 134–139, 2009 (September) 139
member of the protein kinase D family of serine threonine
kinases. J Biol Chem 2001; 276: 3310–8.
Sturany S, Van Lint J, Gilchrist A, 8. et al. Mechanism
of activation of protein kinase D2 (PKD2) by the CCKB/
gastrin receptor. J Biol Chem 2002; 277: 29431–8.
Jones RG, Trowbridge DB, Go MF. 9. Helicobacter pylori
infection in peptic ulcer disease and gastric malignancy. Front
Biosci 2001; 6: 213–26.
Amieva MR, Vogelmann R, Covacci A, 10. et al. Disruption
of the epithelial apical-junctional complex by Helicobacter
pylori CagA. Science 2003; 300: 1430–4.
Backert, S, Moese S, Selbach S, 11. et al. Phosphoryla-
tion of tyrosine 972 of the Helicobacter pylori CagA protein
is essential for induction of a scattering phenotype in gastric
epithelial cells. Mol Microbiol 2001; 42: 631–44.
Selbach, M, Moese S, Hauck CR, 12. et al. Src is the ki-
nase of the Helicobacter pylori CagA protein in vitro and in vivo.
J Biol Chem 2002; 277: 6775–8.
Stein MF, Bagnoli R, Halenbeck R, 13. et al. c-Src/Lyn ki-
nases activate Helicobacter pylori CagA through tyrosine phospho-
rylation of the EPIYA motifs. Mol Microbiol 2002; 43: 971–80.
Tsutsumi R, Higashi H, Higuchi M, 14. et al. Attenuation
of Helicobacter pylori CagA SHP-2 signaling by interaction
between CagA and C-terminal Src kinase. J Biol Chem 2003;
278: 3664–70.
Nozawa Y, Nishihara K, Akizawa Y, 15. et al. Protein kinase
C activation by Helicobacter pylori in human gastric epithelial cells
limits interleukin-8 production through suppression of extracel-
lular signal-regulated kinase. J Pharmacol Sci 2004; 94: 233–9.
Brandt S, Wessler S, Hartig R, 16. et al. Helicobacter pylori
activates protein kinase C delta to control Raf in MAP kinase
signalling: role in AGS epithelial cell scattering and elongation.
Cell Motil Cytoskeleton 2009; DOI 10.1002/cm.20373.
Shabelnik MY, Tarasova TA, Merencev SV, 17. et al.
The level of expression and autophosphorylation of protein
kinase D1 and D2 in gastric adenocarcinoma of different level
of differentiation. Oncology 2008; 10: 393–9 (In Ukrainian).
Hamilton SR, Aaltoneb LA (eds). 18. World Health Organi-
zation classification of tumours. Pathology and genetics of tu-
mours of the digestive system. Lyon: IARC Press, 2000: 253.
Waldron R, Rey O, Iglesias T, 19. et al. Activation loop
Ser744 and Ser748 in protein kinase D are transphosphory-
lated in vivo. J Biol Chem 2001; 276: 32606–15.
Gramley WA, Asghar A, Frierson HF, 20. et al. Detection
of Helicobacter pylori DNA in fecal samples from infected
individuals. Clin Microbiol 1999; 37: 2236–40.
Weiss J, Mecca J, Silva E, Gassner D. 21. Comparison
of PCR and other diagnostic techniques for detection of Heli-
cobacter pylori infection in dyspeptic patients. J Clin Microbiol
1994; 32: 1663–8.
Webb PM, Crabtree JE, Forman D, 22. et al. Gastric can-
cer, cytotoxin-associated gene A-positive Helicobacter pylori,
and serum pepsinogens: an international study. Gastroentero-
logy 1999; 116: 269–76.
Sande N, Nikulin M, Nilsson I, 23. et al. Increased risk
of developing atrophic gastritis in patients infected with CagA+
Helicobacter pylori. Scand J Gastroenterol 2001; 36: 928–33.
Hatakeyama M, Higashi H. 24. Helicobacter pylori CagA:
a new paradigm of bacterial carcinogenesis. Cancer Sci 2005;
96: 835–43.
Quante M, Wang TC. 25. Inflammation and stem cells
in gastrointestinal carcinogenesis. Physiology 2008; 23: 350–9.
Colotta F, Allavena P, Sica A, 26. et al. Cancer-related
inflammation, the seventh hallmark of cancer: links to genetic
instability. Carcinogenesis 2009; 30: 1073–81.
PortalCelhay C, PerezPerez GI. 27. Immune responses
to Helicobacter pylori colonization: mechanisms and clinical
outcomes. Clin Sci 2006; 110: 305–14.
Xia G, SchneiderStock R, Diestel A, 28. et al. Helicobacter
pylori regulates p21WAF1 by histone H4 acetylation. Biochem
Biophys Res Comm 2008; 369: 526–53.
Amieva MR, ElOmar EM. 29. Host-bacterial interac-
tions in Helicobacter pylori infection. Gastroenterology 2008;
134: 306–23.
Beswick EJ, Reyes VE. 30. CD74 in antigen presentation,
inflammation, and cancers of the gastrointestinal tract. World
J Gastroenterol 2009; 15: 2855–61.
Sharma SA, Tummuru MK, Blaser MJ, 31. et al. Activa-
tion of IL-8 gene expression by Helicobacter pylori is regulated
by transcription factor nuclear factor-κB in gastric epithelial
cells. J Immunol 1998; 160: 2401–7.
Majid MA, Faruq TI, Hossain AB. 32. Association of He-
licobacter pylori infection with gastric carcinoma. Bangladesh
Med Res Counc Bull 2009; 35: 7–10.
MurataKamiya N, Kurashima Y, Teishikata Y, 33. et al. He-
licobacter pylori CagA interacts with E-cadherin and deregulates
the β-catenin signal that promotes intestinal transdifferentiation
in gastric epithelial cells. Oncogene 2007; 26: 4617–26.
Du C, Jaggi M, Zhang C, Balaji KC. 34. Protein kinase
D1-mediated phosphorylation and subcellular localization
of beta-catenin. Cancer Res 2009; 69: 1117–24.
Kim M, Jang HR, Kim JH, 35. et al. Epigenetic inactivation
of protein kinese D1 in gastric cancer and its role in gastric cancer
cell migration and invasion. Carcinogenesis 2008; 29: 629–37.
Eiseler T, Dőppler H, Yan IK, 36. et al. Protein kinase
D1 regulates matrix metalloproteinase expression and inhibits
breast cancer cell invasion. Brest Cancer Res 2009; 11: R13.
Achyut BR, Ghoshal UC, Moorchung N, 37. et al. Transfor-
ming grows factor-B1 and matrix metalloproteinase-7 promoter
variants induce risk for Helicobacter pylori-associated gastric
precancerous lesions. DNA Cell Biol 2009; 28: 295–301.
Tomita M, Ando T, Minami M, 38. et al. Potential role
for matrix metalloproteinase-3 in gastric ulcer healing. Diges-
tion 2009; 79: 23–9.
Copyright © Experimental Oncology, 2009
|